News & Updates
Filter by Specialty:
COVID-19 medicine use in pregnancy increases with disease severity
Use of medicines for COVID-19 during pregnancy is higher in patients with more severe disease, according to a study. In addition, a trend towards increased corticosteroids use has been observed and appears to be consistent with changing guidelines.
COVID-19 medicine use in pregnancy increases with disease severity
19 Apr 2023
MV-140 vaccine proven safe, effective in recurrent UTI
Immunotherapy with MV-140 (Uromune) successfully prevents urinary tract infections (UTIs) in patients suffering from recurrent UTIs, suggest the results of a prospective study presented at the 38th Annual EAU Congress (EAU 2023).
MV-140 vaccine proven safe, effective in recurrent UTI
18 Apr 2023
Valaciclovir suppresses Epstein-Barr virus in COPD patients
Treatment with valaciclovir leads to efficacious suppression of Epstein-Barr virus (EBV), having the potential to reduce the sputum inflammatory cell infiltrate, in patients with chronic obstructive pulmonary disease (COPD), according to data from the EViSCO study.
Valaciclovir suppresses Epstein-Barr virus in COPD patients
08 Apr 2023
Online telepharmacy service delivers despite pandemic-related restrictions
A free online telepharmacy service, developed in the Philippines during the COVID-19 pandemic, may be used to provide and simplify medication information as part of primary care, reports a study.
Online telepharmacy service delivers despite pandemic-related restrictions
04 Apr 2023
Tumour immune barrier determines immunotherapy efficacy in HCC
A tumour immune barrier (TIB) structure formed by the interaction of SPP1+ macrophages and cancer-associated fibroblasts (CAFs) appears to influence the efficacy of immunotherapy in patients with hepatocellular carcinoma (HCC), reveals a study.
